Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Daclatasvir bulk supplier for pharma manufacturers

Daclatasvir 30 mg, 60 mg Suppliers & Bulk Manufacturers

Available Forms: Tablet

Available Strengths: 30 mg, 60 mg

Reference Brands: Daklinza® (US & EU)

Category: Hepatitis

Daclatasvir is an effective oral antiviral used to treat chronic Hepatitis C infection by inhibiting the NS5A protein critical for viral replication. Available as 30 mg and 60 mg tablets, it is manufactured under EU-GMP and USFDA standards. Widely used in combination therapies, Daclatasvir supports broad HCV genotype coverage. Ideal for B2B supply, hospital tenders, and licensing, it comes with comprehensive regulatory dossiers enabling quick registration in global markets.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description: Daclatasvir is a potent direct-acting antiviral (DAA) used in the treatment of chronic Hepatitis C virus (HCV) infection. It functions by selectively inhibiting the NS5A protein, a key factor in viral replication and assembly. Available as oral tablets in strengths of 30 mg and 60 mg, Daclatasvir is commonly used in combination with Sofosbuvir or other antivirals for broad genotype coverage. Manufactured under strict EU-GMP and USFDA standards, it is suitable for B2B supply, hospital tenders, and licensing. Comprehensive regulatory dossiers support fast market registration and global distribution.

Daclatasvir — third party manufacturing & bulk supply

Daclatasvir 30 mg, 60 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Daclatasvir is supplied as Tablet — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Daclatasvir listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Daclatasvir →
Back to Listing

Frequently Asked Questions

Daclatasvir is listed as Tablet in 30 mg, 60 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Daclatasvir is referenced against Daklinza® (US & EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.

Related Products

Daclatasvir/ Sofosbuvir

Strength:
Daclatasvir 60 mg + Sofosbuvir 400 mg

Form: Tablet

Reference Brands: Hepcinat Plus (India), Myhep Dvir (India)

View Details
Pegylated Interferon Alpha-1A

Strength:
120 mcg, 150 mcg, 180 mcg

Form: Injection

Reference Brands: Pegasys® (US & EU), PegIntron® (EU)

View Details
Human Normal Immunoglobulin

Strength:
IVIG: 5%, 10%, 16%, 20%; SCIG: 20%

Form: (IVIG) & (SCIG)

Reference Brands: Privigen®, Gamunex-C® (EU & US),Flebogamma (LATAM)

View Details
Interferon Alfa-2B

Strength:
3 million IU/vial, 5 million IU/vial, 10 million IU/vial

Form: Lyophilized Powder for Injection

Reference Brands: Intron A® (EU & US), Roferon-A®(EU), Virafin (Indila)

View Details
Ribavirin

Strength:
Tablet:200 mg, 400 mg, 600mg; Capsule:200 mg; Solution:40 mg/mL

Form: Tablets, Capsules and Oral Solution

Reference Brands: Rebetol®, Copegus®, Virazole®(EU & US)

View Details
Ombitasvir/Paritaprevir/Ritonavir + Dasabuvir

Strength:
Ombitasvir 12.5 mg / Paritaprevir 75 mg / Ritonavir 50 mg (tablet)+ Dasabuvir 250 mg (tablet)

Form: Tablet

Reference Brands: Viekira Pak® (US); Viekirax® + Exviera® (EU)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.